-
1
-
-
34248384541
-
Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers
-
M. Tomita, S. Mizuno, H. Yamanaka, and et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers J. Epidemiol. 10 2000 403 409
-
(2000)
J. Epidemiol.
, vol.10
, pp. 403-409
-
-
Tomita, M.1
Mizuno, S.2
Yamanaka, H.3
-
3
-
-
0024508912
-
Serum uric acid and 11.5-year mortality of middle-aged women: Findings of the Chicago Heart Association Detection Project in Industry
-
W. Levine, A.R. Dyer, R.B. Shekelle, J.A. Schoenberger, and J. Stamler Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry J. Clin. Epidemiol. 42 3 1989 257 267
-
(1989)
J. Clin. Epidemiol.
, vol.42
, Issue.3
, pp. 257-267
-
-
Levine, W.1
Dyer, A.R.2
Shekelle, R.B.3
Schoenberger, J.A.4
Stamler, J.5
-
4
-
-
73649149434
-
Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: Its prognostic role and relation with inflammatory markers: A single center experience
-
C. Lazzeri, S. Valente, M. Chiostri, A. Sori, P. Bernardo, and G.F. Gensini Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience Int. J. Cardiol. 138 2 2010 206 209
-
(2010)
Int. J. Cardiol.
, vol.138
, Issue.2
, pp. 206-209
-
-
Lazzeri, C.1
Valente, S.2
Chiostri, M.3
Sori, A.4
Bernardo, P.5
Gensini, G.F.6
-
5
-
-
0027939881
-
Impaired lipoprotein metabolism in patients with primary gout-influence of alcohol intake and body weight
-
S. Takahashi, T. Yamamoto, Y. Moriwaki, Z. Tsutsumi, and K. Higashino Impaired lipoprotein metabolism in patients with primary gout-influence of alcohol intake and body weight Br. J. Rheumatol. 33 1994 731 734
-
(1994)
Br. J. Rheumatol.
, vol.33
, pp. 731-734
-
-
Takahashi, S.1
Yamamoto, T.2
Moriwaki, Y.3
Tsutsumi, Z.4
Higashino, K.5
-
6
-
-
0035055141
-
Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout
-
S. Takahashi, Y. Moriwaki, Z. Tsutsumi, J. Yamakita, T. Yamamoto, and T. Hada Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout Metabolism 50 2001 393 398
-
(2001)
Metabolism
, vol.50
, pp. 393-398
-
-
Takahashi, S.1
Moriwaki, Y.2
Tsutsumi, Z.3
Yamakita, J.4
Yamamoto, T.5
Hada, T.6
-
7
-
-
0345314392
-
The effect of a low purine diet and allopurinol on serum urate concentrations
-
B.T. Emmerson The effect of a low purine diet and allopurinol on serum urate concentrations Aust. Ann. Med. 16 1969 205 214
-
(1969)
Aust. Ann. Med.
, vol.16
, pp. 205-214
-
-
Emmerson, B.T.1
-
8
-
-
0037449776
-
An extremely potent inhibitor of xanthine oxidoreductase: Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
-
K. Okamoto, B.T. Eger, T. Nishino, S. Kondo, E.F. Pai, and T. Nishino An extremely potent inhibitor of xanthine oxidoreductase: crystal structure of the enzyme-inhibitor complex and mechanism of inhibition J. Biol. Chem. 278 2003 1848 1855
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 1848-1855
-
-
Okamoto, K.1
Eger, B.T.2
Nishino, T.3
Kondo, S.4
Pai, E.F.5
Nishino, T.6
-
9
-
-
10344260696
-
Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers
-
M.A. Becker, J. Kisicki, R. Khosravan, and et al. Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers Nucleosides Nucleotides Nucleic Acids 23 2004 1111 1116
-
(2004)
Nucleosides Nucleotides Nucleic Acids
, vol.23
, pp. 1111-1116
-
-
Becker, M.A.1
Kisicki, J.2
Khosravan, R.3
-
11
-
-
67650844186
-
Fenofibrate: Simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients
-
G. Derosa, P. Maffioli, S.A. Salvadeo, and et al. Fenofibrate: simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients Curr. Med. Res. Opin. 25 8 2009 1973 1983
-
(2009)
Curr. Med. Res. Opin.
, vol.25
, Issue.8
, pp. 1973-1983
-
-
Derosa, G.1
Maffioli, P.2
Salvadeo, S.A.3
-
12
-
-
0036894204
-
Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease
-
K.A. Packard, J.M. Backes, T.L. Lenz, R.L. Wurdeman, C. Destache, and D.E. Hilleman Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease Pharmacotherapy 22 12 2002 1527 1532
-
(2002)
Pharmacotherapy
, vol.22
, Issue.12
, pp. 1527-1532
-
-
Packard, K.A.1
Backes, J.M.2
Lenz, T.L.3
Wurdeman, R.L.4
Destache, C.5
Hilleman, D.E.6
-
13
-
-
69449100622
-
PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
-
(2009)
BMJ
, vol.339
, pp. b2535
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
17
-
-
84876135427
-
Does PPARγ2 gene Pro12Ala polymorphism affect non alcoholic fatty liver disease risk? Evidence from a meta-analysis
-
A. Sahebkar Does PPARγ2 gene Pro12Ala polymorphism affect non alcoholic fatty liver disease risk? Evidence from a meta-analysis DNA Cell Biol. 32 4 2013 188 198
-
(2013)
DNA Cell Biol.
, vol.32
, Issue.4
, pp. 188-198
-
-
Sahebkar, A.1
-
18
-
-
84899477785
-
Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis
-
A. Sahebkar Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis Phytother. Res. 28 5 2014 633 642
-
(2014)
Phytother. Res.
, vol.28
, Issue.5
, pp. 633-642
-
-
Sahebkar, A.1
-
19
-
-
0033934949
-
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
-
S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
-
(2000)
Biometrics
, vol.56
, pp. 455-463
-
-
Duval, S.1
Tweedie, R.2
-
20
-
-
0033384110
-
Atherogenic lipoprotein phenotype in type 2 diabetes: Reversal with micronised fenofibrate
-
M.D. Feher, M. Caslake, J. Foxton, A. Cox, and C.J. Packard Atherogenic lipoprotein phenotype in type 2 diabetes: reversal with micronised fenofibrate Diabetes Metab. Res. Rev. 15 6 1999 395 399
-
(1999)
Diabetes Metab. Res. Rev.
, vol.15
, Issue.6
, pp. 395-399
-
-
Feher, M.D.1
Caslake, M.2
Foxton, J.3
Cox, A.4
Packard, C.J.5
-
21
-
-
0036810635
-
Effects of fenofibrate on high-density lipoprotein particle size in patients with hyperlipidemia: A randomized, double-blind, placebo-controlled, multicenter, crossover study
-
J. Sasaki, K. Yamamoto, and M. Ageta Effects of fenofibrate on high-density lipoprotein particle size in patients with hyperlipidemia: a randomized, double-blind, placebo-controlled, multicenter, crossover study Clin. Ther. 24 10 2002 1614 1626
-
(2002)
Clin. Ther.
, vol.24
, Issue.10
, pp. 1614-1626
-
-
Sasaki, J.1
Yamamoto, K.2
Ageta, M.3
-
22
-
-
0036890093
-
Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus
-
D.A. Playford, G.F. Watts, J.D. Best, and V. Burke Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus Am. J. Cardiol. 90 11 2002 1254 1257
-
(2002)
Am. J. Cardiol.
, vol.90
, Issue.11
, pp. 1254-1257
-
-
Playford, D.A.1
Watts, G.F.2
Best, J.D.3
Burke, V.4
-
23
-
-
0141617491
-
Effects of fenofibrate on albuminuria in patients with hypertriglyceridemia and/or hyperuricemia: A multicenter, randomized, double-blind, placebo-controlled, crossover study
-
T. Kazumi, T. Hirano, G. Yoshino, and For The Fenofibrate Study Group Effects of fenofibrate on albuminuria in patients with hypertriglyceridemia and/or hyperuricemia: a multicenter, randomized, double-blind, placebo-controlled, crossover study Curr. Ther. Res. Clin. Exp. 64 7 2003 434 446
-
(2003)
Curr. Ther. Res. Clin. Exp.
, vol.64
, Issue.7
, pp. 434-446
-
-
Kazumi, T.1
Hirano, T.2
Yoshino, G.3
-
24
-
-
0023905821
-
Hypertriglyceridemia and hyperuricemia: Effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial
-
M.D. Bastow, P.N. Durrington, and M. Ishola Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial Metabolism 37 3 1988 217 220
-
(1988)
Metabolism
, vol.37
, Issue.3
, pp. 217-220
-
-
Bastow, M.D.1
Durrington, P.N.2
Ishola, M.3
-
25
-
-
43849083545
-
Effect of fenofibrate on kidney function: A 6-week randomized crossover trial in healthy people
-
J.C. Ansquer, R.N. Dalton, E. Caussé, D. Crimet, K. Le Malicot, and C. Foucher Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people Am. J. Kidney Dis. 51 6 2008 904 913
-
(2008)
Am. J. Kidney Dis.
, vol.51
, Issue.6
, pp. 904-913
-
-
Ansquer, J.C.1
Dalton, R.N.2
Caussé, E.3
Crimet, D.4
Le Malicot, K.5
Foucher, C.6
-
26
-
-
0033998334
-
The PPARs from orphan receptors to drug discovery
-
T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs from orphan receptors to drug discovery J. Med. Chem. 43 4 2000 527 550
-
(2000)
J. Med. Chem.
, vol.43
, Issue.4
, pp. 527-550
-
-
Willson, T.M.1
Brown, P.J.2
Sternbach, D.D.3
Henke, B.R.4
-
28
-
-
75749156653
-
Effect of fenofibrate on uric acid metabolism and urate transporter 1
-
D. Uetake, I. Ohno, K. Ichida, and et al. Effect of fenofibrate on uric acid metabolism and urate transporter 1 Intern. Med. 49 2 2010 89 94
-
(2010)
Intern. Med.
, vol.49
, Issue.2
, pp. 89-94
-
-
Uetake, D.1
Ohno, I.2
Ichida, K.3
-
29
-
-
0037161834
-
Molecular identification of a renal urate anion exchanger that regulates blood urate levels
-
A. Enomoto, H. Kimura, A. Chairoungdua, and et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels Nature 417 6887 2002 447 452
-
(2002)
Nature
, vol.417
, Issue.6887
, pp. 447-452
-
-
Enomoto, A.1
Kimura, H.2
Chairoungdua, A.3
-
30
-
-
84906653638
-
Recent advances in pharmacotherapy for hypertriglyceridemia
-
A. Sahebkar, G.T. Chew, and G.F. Watts Recent advances in pharmacotherapy for hypertriglyceridemia Prog. Lipid Res. 56 2014 47 66
-
(2014)
Prog. Lipid Res.
, vol.56
, pp. 47-66
-
-
Sahebkar, A.1
Chew, G.T.2
Watts, G.F.3
-
31
-
-
84882927131
-
New LDL-cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes
-
A. Sahebkar, and G.F. Watts New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes Clin. Ther. 35 8 2013 1082 1098
-
(2013)
Clin. Ther.
, vol.35
, Issue.8
, pp. 1082-1098
-
-
Sahebkar, A.1
Watts, G.F.2
-
32
-
-
84892369781
-
New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: What can the clinician expect?
-
A. Sahebkar, and G.F. Watts New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? Cardiovasc Drugs Ther. 27 6 2013 559 567
-
(2013)
Cardiovasc Drugs Ther.
, vol.27
, Issue.6
, pp. 559-567
-
-
Sahebkar, A.1
Watts, G.F.2
-
33
-
-
84905746950
-
Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: Tale of a roller-coaster
-
A. Sahebkar, and G.F. Watts Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: tale of a roller-coaster Diabetes Obes. Metab. 16 9 2014 780 792
-
(2014)
Diabetes Obes. Metab.
, vol.16
, Issue.9
, pp. 780-792
-
-
Sahebkar, A.1
Watts, G.F.2
-
34
-
-
84893649359
-
New peroxisome proliferator-activated receptor agonists: Potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease
-
A. Sahebkar, G.T. Chew, and G.F. Watts New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease Expert Opin. Pharmacother. 15 4 2014 493 503
-
(2014)
Expert Opin. Pharmacother.
, vol.15
, Issue.4
, pp. 493-503
-
-
Sahebkar, A.1
Chew, G.T.2
Watts, G.F.3
|